MedTrace Logo

Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans

NCT01727895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-07-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test wether orally administered Beta-glucan has systemic effects in humans.

Conditions

  • Immunologic Deficiency Syndromes

Interventions

DIETARY_SUPPLEMENT

Beta-glucan (Glucan #300®)

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Mihai Netea, MD, PhD · Radboud University Nijmegen Medical Centre, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
36 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01727895 on ClinicalTrials.gov